Cargando…
Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to global health. The mortality rate of severely ill patients in the early stage is 32.5%. The exacerbation of the condition and deat...
Autores principales: | Wu, Yingjie, Huang, Xiaoxing, Sun, Jiaxing, Xie, Tian, Lei, Yufei, Muhammad, Jamal, Li, Xinran, Zeng, Xingruo, Zhou, Fuling, Qin, Hong, Shao, Liang, Zhang, Qiuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364211/ https://www.ncbi.nlm.nih.gov/pubmed/32669467 http://dx.doi.org/10.1128/mSphere.00362-20 |
Ejemplares similares
-
CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
por: Sun, Jiaxing, et al.
Publicado: (2020) -
CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis
por: Jamal, Muhammad, et al.
Publicado: (2023) -
Uridine‐cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer
por: Wu, Yingjie, et al.
Publicado: (2019) -
Immune dysregulation and system pathology in COVID-19
por: Jamal, Muhammad, et al.
Publicado: (2021) -
Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021)